|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
Sec Filings Insider Trading - DOV Pharmaceutical Inc. (DOVP.OB)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |
DOV Pharmaceutical Inc: Insider Trading and Stock Options
Common stock purchase or sale:
| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2008-11-19 Purchase |
2008-11-21 06:22 am | DOV PHARMACEUTICAL INC | DOVP | Zakrzewski Joseph S (Director) | 772,327 | $0.003 | $2,317 | 1,509,292 (Direct) | View |
| 2008-09-30 Purchase | 2008-10-08 9:42 pm |
DOV PHARMACEUTICAL INC | DOVP | Zakrzewski Joseph S (Director) | 125,000 | $0.04 | $5,000 | 736,702 (Direct) |
View |
| 2008-09-12- -2008-09-15 Purchase | 2008-09-15 7:31 pm | DOV PHARMACEUTICAL INC | DOVP | Zakrzewski Joseph S (Director) | 26,500 | $0.037 | $980 | 611,702 (Direct) | View |
| 2008-09-05- -2008-09-09 Purchase |
2008-09-09 5:11 pm |
DOV PHARMACEUTICAL INC | DOVP | Zakrzewski Joseph S (Director) | 59,881 | $0.037 | $2,216 | 585,202 (Direct) | View |
| 2008-08-27 Purchase | 2008-09-02 4:24 pm |
DOV PHARMACEUTICAL INC | DOVP | Zakrzewski Joseph S (Director) | 200,000 | $0.035 | $7,000 | 525,321 (Direct) |
View |
| 2008-07-16 Purchase |
2008-07-18 4:36 pm | DOV PHARMACEUTICAL INC | DOVP | Zakrzewski Joseph S (Director) | 10,495 | $0.036 | $378 | 225,321 (Direct) |
View |
| 2008-06-27- -2008-06-30 Purchase |
2008-07-01 4:30 pm | DOV PHARMACEUTICAL INC | DOVP | Zakrzewski Joseph S (Director) | 76,826 | $0.036 | $2,766 | 214,826 (Direct) | View |
| 2007-09-07 Purchase | 2007-09-10 11:21 am | DOV PHARMACEUTICAL INC | DOVP | DOV PHARMACEUTICAL INC (Director) | 25,000 | $0.2 | $5,000 | 25,000 (Direct) | View |
| 2006-05-16 Sale | 2006-05-18 11:02 am | DOV PHARMACEUTICAL INC | DOVP | ORBIMED ADVISORS LLC ISALY SAMUEL D ORBIMED CAPITAL LLC (Director) | 817,771 | $3.25 | $2,657,756 | 258,000 (Indirect) |
View |
| 2004-08-25 Sale | 2004-08-27 1:36 pm | DOV PHARMACEUTICAL INC | DOVP | ELAN CORP PLC ELAN INTERNATIONAL SERVICES LTD (10% owner) | 1,945,362 | $14.75 | $28,694,090 | 0 (Indirect) | View |
| 2004-08-23 Sale | 2004-08-25 4:29 pm | DOV PHARMACEUTICAL INC | DOVP | ELAN CORP PLC (10% owner) | 250,000 | $15.25 | $3,812,500 | 1,945,362 (Indirect) |
View |
| 2004-06-30- -2004-07-01 Sale |
2004-07-02 4:22 pm |
DOV PHARMACEUTICAL INC | DOVP | ELAN CORP PLC ELAN PHARMACEUTICAL INVESTMENTS LTD ELAN INTERNATIONAL SERVICES LTD (10% owner) | 323,699 | $13.96 | $4,519,891 | 2,720,162 (Indirect) |
View |
Other purchase or sale (not a common stock or no ticker symbol):
| Transaction & Date |
Reported Date |
Company | Symbol | Insider Relationship | Shares Traded | Average Price |
Total Amount | Shares Ownership |
Filing |
| 2008-04-03 Purchase |
2008-04-08 08:30 am | DOV PHARMACEUTICAL INC | DOVP | DOV PHARMACEUTICAL INC (Director) | 100,000 | $0.053 | $5,300 | 138,000 (Direct) |
View |
| 2008-01-09 Purchase | 2008-01-17 5:53 pm | DOV PHARMACEUTICAL INC | DOVP | DOV PHARMACEUTICAL INC (Director) | 13,800 | $0.07 | $966 | 38,700 (Direct) | View |
Other transactions:
| Transaction & Date | Reported Date | Company | Symbol | Insider Relationship | Shares Traded |
Average Price |
Total Amount | Shares Ownership |
Filing |
| 2008-09-30 Option Award(A) |
2008-10-08 9:58 pm |
DOV PHARMACEUTICAL INC | DOVP | Zakrzewski Joseph S (Director) | 125,000 | $0.04 | $5,000 | 736,702 (Direct) |
View |
| 2007-06-18 Other |
2007-06-20 3:42 pm | DOV PHARMACEUTICAL INC | DOVP | UBS AG (No longer a 10% holder.) | 2,500,000 | $0 | $0 | 9,725,672 (Direct) | View |
| 2007-06-11 Purchase | 2007-06-13 7:33 pm | DOV PHARMACEUTICAL INC | DOVP | HIGHBRIDGE CAPITAL MANAGEMENT LLC Highbridge International LLC Dubin Glenn Swieca Henry (10% owner) | 13,295,418 | $0 | $0 | 13,295,418 (Indirect) | View |
| 2007-06-11 Purchase | 2007-06-12 5:19 pm |
DOV PHARMACEUTICAL INC | DOVP | POLYGON GLOBAL OPPORTUNITIES MASTER FUND Polygon Investment Partners LLP Polygon Investment Partners LP Polygon Investment Partners HK LTD Polygon Investments Ltd. Polygon Investment Management LTD Polygon Investment Partners GP, LLC Reade E. Griffith Alexander E. Jackson Patrick G. G. Dear (10% owner) | 12,225,672 | $0 | $0 | 12,225,672 (Direct) |
View |
(A) Indicate amendment filing.
Stock options: Exercise, Award, Grant, Conversion
| Transaction & Date | Reported Date |
Exercisable Expiration | Company | Symbol | Insider Relationship | Shares Traded | Conversion Price |
Shares Ownership | Filing |
| 2008-05-16 Option Award | 2008-05-23 9:42 pm | N/A 2017-08-09 | DOV PHARMACEUTICAL INC | DOVP | Skolnick Phil (President and CSO) | 1,300,000 | $0.04 | 2,935,000 (Direct) | View |
| 2008-05-16 Option Award |
2008-05-23 9:42 pm | N/A 2017-08-09 | DOV PHARMACEUTICAL INC | DOVP | Skolnick Phil (President and CSO) | 635,000 | $0.1 | 2,935,000 (Direct) |
View |
| 2008-05-16 Option Award | 2008-05-23 9:42 pm |
N/A 2017-08-09 |
DOV PHARMACEUTICAL INC | DOVP | Skolnick Phil (President and CSO) | 500,000 | $0.2 | 2,935,000 (Direct) |
View |
| 2008-05-16 Option Award | 2008-05-23 9:42 pm |
N/A 2017-08-09 | DOV PHARMACEUTICAL INC | DOVP | Skolnick Phil (President and CSO) | 500,000 | $0.25 | 2,935,000 (Direct) | View |
| 2008-05-16 Option Award | 2008-05-23 9:42 pm |
N/A 2017-08-09 |
DOV PHARMACEUTICAL INC | DOVP | Skolnick Phil (President and CSO) | 500,000 | $0 | 3,435,000 (Direct) | View |
| 2008-05-16 Option Award |
2008-05-23 9:16 pm |
N/A 2017-08-09 | DOV PHARMACEUTICAL INC | DOVP | Duncan Barbara Gayle (CEO Director) | 1,430,000 | $0.04 | 3,228,500 (Direct) |
View |
| 2008-05-16 Option Award |
2008-05-23 9:16 pm |
N/A 2017-08-09 |
DOV PHARMACEUTICAL INC | DOVP | Duncan Barbara Gayle (CEO Director) | 698,500 | $0.1 | 3,228,500 (Direct) | View |
| 2008-05-16 Option Award |
2008-05-23 9:16 pm | N/A 2017-08-09 |
DOV PHARMACEUTICAL INC | DOVP | Duncan Barbara Gayle (CEO Director) | 550,000 | $0.2 | 3,228,500 (Direct) | View |
| 2008-05-16 Option Award | 2008-05-23 9:16 pm |
N/A 2017-08-09 | DOV PHARMACEUTICAL INC | DOVP | Duncan Barbara Gayle (CEO Director) | 550,000 | $0.25 | 3,228,500 (Direct) |
View |
| 2008-05-16 Option Award | 2008-05-23 9:16 pm |
N/A 2017-08-09 | DOV PHARMACEUTICAL INC | DOVP | Duncan Barbara Gayle (CEO Director) | 550,000 | $0 | 3,778,500 (Direct) | View |
| 2008-05-16 Option Award |
2008-05-23 9:15 pm |
N/A 2018-05-16 |
DOV PHARMACEUTICAL INC | DOVP | Lippa Arnold (Director) | 260,000 | $0.04 | 387,000 (Direct) |
View |
| 2008-05-16 Option Award |
2008-05-23 9:15 pm | N/A 2017-08-09 | DOV PHARMACEUTICAL INC | DOVP | Lippa Arnold (Director) | 127,000 | $0.1 | 387,000 (Direct) |
View |
| 2008-05-16 Option Award |
2008-05-23 9:14 pm |
N/A 2018-05-16 | DOV PHARMACEUTICAL INC | DVOP | Podlesak Dennis (Director) | 260,000 | $0.04 | 387,000 (Direct) | View |
| 2008-05-16 Option Award | 2008-05-23 9:14 pm | N/A 2017-08-09 | DOV PHARMACEUTICAL INC | DVOP | Podlesak Dennis (Director) | 127,000 | $0.1 | 387,000 (Direct) | View |
| 2008-05-16 Option Award | 2008-05-23 9:13 pm | N/A 2018-05-16 | DOV PHARMACEUTICAL INC | DOVP | VAN RIPER DANIEL S (Director) | 260,000 | $0.04 | 387,000 (Direct) |
View |
| 2008-05-16 Option Award | 2008-05-23 9:13 pm | N/A 2017-08-09 |
DOV PHARMACEUTICAL INC | DOVP | VAN RIPER DANIEL S (Director) | 127,000 | $0.1 | 387,000 (Direct) | View |
| 2008-05-16 Option Award |
2008-05-23 9:12 pm | N/A 2018-05-16 |
DOV PHARMACEUTICAL INC | DOVP | Zakrzewski Joseph S (Director) | 260,000 | $0.04 | 387,000 (Direct) | View |
| 2008-05-16 Option Award | 2008-05-23 9:12 pm | N/A 2017-08-09 |
DOV PHARMACEUTICAL INC | DOVP | Zakrzewski Joseph S (Director) | 127,000 | $0.1 | 387,000 (Direct) | View |
| 2008-05-16 Option Award | 2008-05-23 9:11 pm | N/A 2018-05-16 | DOV PHARMACEUTICAL INC | DOVP | Ashe Patrick (Director) | 260,000 | $0.04 | 387,000 (Direct) | View |
| 2008-05-16 Option Award |
2008-05-23 9:11 pm |
N/A 2017-08-09 |
DOV PHARMACEUTICAL INC | DOVP | Ashe Patrick (Director) | 127,000 | $0.1 | 387,000 (Direct) |
View |
| 2008-05-16 Option Award |
2008-05-23 9:09 pm |
N/A 2018-05-16 |
DOV PHARMACEUTICAL INC | DOVP | HOROVITZ ZOLA P (Director) | 260,000 | $0.04 | 387,000 (Direct) | View |
| 2008-05-16 Option Award |
2008-05-23 9:09 pm | N/A 2017-08-09 |
DOV PHARMACEUTICAL INC | DOVP | HOROVITZ ZOLA P (Director) | 127,000 | $0.1 | 387,000 (Direct) | View |
| 2008-05-16 Option Sale |
2008-05-20 9:18 pm |
2008-08-09 2017-08-09 |
DOV PHARMACEUTICAL INC | DOVP | DOV PHARMACEUTICAL INC (Director) | 127,000 | $0 | 387,000 (Direct) | View |
| 2008-05-16 Option Award | 2008-05-20 9:18 pm | N/A 2018-05-16 | DOV PHARMACEUTICAL INC | DOVP | DOV PHARMACEUTICAL INC (Director) | 260,000 | $0 | 387,000 (Direct) |
View |
| 2008-05-16 Option Award | 2008-05-20 9:18 pm |
N/A 2018-05-16 |
DOV PHARMACEUTICAL INC | DOVP | DOV PHARMACEUTICAL INC (Director) | 127,000 | $0 | 387,000 (Direct) |
View |
| 2008-05-16 Option Sale |
2008-05-20 9:17 pm |
N/A N/A | DOV PHARMACEUTICAL INC | DOVP | VAN RIPER DANIEL S (Director) | 184,150 | $0 | 387,000 (Direct) | View |
| 2008-05-16 Option Award | 2008-05-20 9:17 pm | N/A 2018-05-16 | DOV PHARMACEUTICAL INC | DOVP | VAN RIPER DANIEL S (Director) | 260,000 | $0 | 387,000 (Direct) | View |
| 2008-05-16 Option Award |
2008-05-20 9:17 pm | N/A 2018-05-16 | DOV PHARMACEUTICAL INC | DOVP | VAN RIPER DANIEL S (Director) | 127,000 | $0 | 387,000 (Direct) |
View |
| 2008-05-16 Option Sale |
2008-05-20 9:17 pm | 2008-08-09 2017-08-09 | DOV PHARMACEUTICAL INC | DOVP | Podlesak Dennis (Director) | 127,000 | $0 | 127,000 (Direct) |
View |
| 2008-05-16 Option Award |
2008-05-20 9:17 pm |
N/A 2018-05-16 | DOV PHARMACEUTICAL INC | DOVP | Podlesak Dennis (Director) | 260,000 | $0 | 387,000 (Direct) | View |
| 2008-05-16 Option Award | 2008-05-20 9:17 pm | N/A 2018-05-16 | DOV PHARMACEUTICAL INC | DOVP | Podlesak Dennis (Director) | 127,000 | $0 | 387,000 (Direct) |
View |
| 2008-05-16 Option Sale |
2008-05-20 9:16 pm |
N/A N/A | DOV PHARMACEUTICAL INC | DOVP | Lippa Arnold (Director) | 407,600 | $0 | 387,000 (Direct) |
View |
| 2008-05-16 Option Award |
2008-05-20 9:16 pm |
N/A 2018-05-16 | DOV PHARMACEUTICAL INC | DOVP | Lippa Arnold (Director) | 260,000 | $0 | 387,000 (Direct) |
View |
| 2008-05-16 Option Award | 2008-05-20 9:16 pm |
N/A 2018-05-16 | DOV PHARMACEUTICAL INC | DOVP | Lippa Arnold (Director) | 127,000 | $0 | 387,000 (Direct) | View |
| 2008-05-16 Option Sale |
2008-05-20 9:16 pm |
N/A N/A |
DOV PHARMACEUTICAL INC | DOVP | HOROVITZ ZOLA P (Director) | 216,300 | $0 | 387,000 (Direct) |
View |
| 2008-05-16 Option Award | 2008-05-20 9:16 pm | N/A 2018-05-16 | DOV PHARMACEUTICAL INC | DOVP | HOROVITZ ZOLA P (Director) | 260,000 | $0 | 387,000 (Direct) |
View |
| 2008-05-16 Option Award |
2008-05-20 9:16 pm |
N/A 2018-05-16 |
DOV PHARMACEUTICAL INC | DOVP | HOROVITZ ZOLA P (Director) | 127,000 | $0 | 387,000 (Direct) | View |
| 2008-05-16 Option Sale |
2008-05-20 9:15 pm |
N/A N/A | DOV PHARMACEUTICAL INC | DOVP | Ashe Patrick (Director) | 248,200 | $0 | 387,000 (Direct) | View |
| 2008-05-16 Option Award | 2008-05-20 9:15 pm | N/A 2018-05-16 |
DOV PHARMACEUTICAL INC | DOVP | Ashe Patrick (Director) | 260,000 | $0 | 387,000 (Direct) |
View |
| 2008-05-16 Option Award | 2008-05-20 9:15 pm | N/A 2018-05-16 |
DOV PHARMACEUTICAL INC | DOVP | Ashe Patrick (Director) | 127,000 | $0 | 387,000 (Direct) |
View |
| 2008-05-16 Option Sale | 2008-05-20 9:14 pm | N/A N/A | DOV PHARMACEUTICAL INC | DOVP | Skolnick Phil (President and CSO) | 5,821,209 | $0 | 3,435,000 (Direct) |
View |
| 2008-05-16 Option Award | 2008-05-20 9:14 pm |
N/A 2018-05-16 |
DOV PHARMACEUTICAL INC | DOVP | Skolnick Phil (President and CSO) | 560,000 | $0 | 3,435,000 (Direct) | View |
| 2008-05-16 Option Award | 2008-05-20 9:14 pm | N/A 2018-05-16 | DOV PHARMACEUTICAL INC | DOVP | Skolnick Phil (President and CSO) | 740,000 | $0 | 3,435,000 (Direct) |
View |
| 2008-05-16 Option Award |
2008-05-20 9:14 pm |
N/A 2018-05-16 | DOV PHARMACEUTICAL INC | DOVP | Skolnick Phil (President and CSO) | 635,000 | $0 | 3,435,000 (Direct) |
View |
| 2008-05-16 Option Award |
2008-05-20 9:14 pm | N/A 2018-05-16 | DOV PHARMACEUTICAL INC | DOVP | Skolnick Phil (President and CSO) | 500,000 | $0 | 3,435,000 (Direct) |
View |
| 2008-05-16 Option Award |
2008-05-20 9:14 pm |
N/A 2018-05-16 | DOV PHARMACEUTICAL INC | DOVP | Skolnick Phil (President and CSO) | 500,000 | $0 | 3,435,000 (Direct) | View |
| 2008-05-16 Option Award |
2008-05-20 9:14 pm | N/A 2018-05-16 | DOV PHARMACEUTICAL INC | DOVP | Skolnick Phil (President and CSO) | 500,000 | $0 | 3,435,000 (Direct) |
View |
| 2008-05-16 Option Sale |
2008-05-20 9:14 pm | N/A N/A |
DOV PHARMACEUTICAL INC | DOVP | Duncan Barbara Gayle (Director) | 5,830,709 | $0 | 3,778,500 (Direct) | View |
| 2008-05-16 Option Award |
2008-05-20 9:14 pm |
N/A 2018-05-16 | DOV PHARMACEUTICAL INC | DOVP | Duncan Barbara Gayle (Director) | 705,500 | $0 | 3,778,500 (Direct) |
View |
| 2008-05-16 Option Award | 2008-05-20 9:14 pm | N/A 2018-05-16 |
DOV PHARMACEUTICAL INC | DOVP | Duncan Barbara Gayle (Director) | 724,500 | $0 | 3,778,500 (Direct) | View |
| 2008-05-16 Option Award |
2008-05-20 9:14 pm | N/A 2018-05-16 | DOV PHARMACEUTICAL INC | DOVP | Duncan Barbara Gayle (Director) | 698,500 | $0 | 3,778,500 (Direct) | View |
| 2008-05-16 Option Award | 2008-05-20 9:14 pm |
N/A 2018-05-16 |
DOV PHARMACEUTICAL INC | DOVP | Duncan Barbara Gayle (Director) | 550,000 | $0 | 3,778,500 (Direct) | View |
| 2008-05-16 Option Award | 2008-05-20 9:14 pm | N/A 2018-05-16 |
DOV PHARMACEUTICAL INC | DOVP | Duncan Barbara Gayle (Director) | 550,000 | $0 | 3,778,500 (Direct) | View |
| 2008-05-16 Option Award | 2008-05-20 9:14 pm |
N/A 2018-05-16 | DOV PHARMACEUTICAL INC | DOVP | Duncan Barbara Gayle (Director) | 550,000 | $0 | 3,778,500 (Direct) | View |
| 2007-08-09 Option Award | 2007-08-13 2:26 pm | N/A 2017-08-09 |
DOV PHARMACEUTICAL INC | DOVP | Skolnick Phil (President and CSO) | 5,031,209 | $0.33 | 5,821,209 (Direct) | View |
| 2007-08-09 Option Award | 2007-08-13 2:18 pm |
N/A 2017-08-09 |
DOV PHARMACEUTICAL INC | DOVP | Duncan Barbara Gayle (CEO Director) | 5,031,209 | $0.33 | 5,830,709 (Direct) | View |
| 2007-08-09 Option Award | 2007-08-13 2:06 pm | N/A N/A | DOV PHARMACEUTICAL INC | DOVP | VAN RIPER DANIEL S (Director) | 100,000 | $0 | 100,000 (Direct) |
View |
| 2007-08-09 Option Award |
2007-08-13 2:06 pm |
N/A 2017-08-09 |
DOV PHARMACEUTICAL INC | DOVP | VAN RIPER DANIEL S (Director) | 127,000 | $0.3 | 184,150 (Direct) |
View |
| 2007-06-11 Purchase | 2007-06-13 7:33 pm |
2007-05-11 2007-06-11 |
DOV PHARMACEUTICAL INC | DOVP | HIGHBRIDGE CAPITAL MANAGEMENT LLC Highbridge International LLC Dubin Glenn Swieca Henry (10% owner) | 13,295,418 | $0 | 0 (Indirect) |
View |
| 2007-06-11 Purchase | 2007-06-12 5:19 pm | 2007-05-11 2007-06-11 |
DOV PHARMACEUTICAL INC | DOVP | POLYGON GLOBAL OPPORTUNITIES MASTER FUND Polygon Investment Partners LLP Polygon Investment Partners LP Polygon Investment Partners HK LTD Polygon Investments Ltd. Polygon Investment Management LTD Polygon Investment Partners GP, LLC Reade E. Griffith Alexander E. Jackson Patrick G. G. Dear (10% owner) | 64,000 | $0 | 12,225,672 (Direct) |
View |
| 2007-01-19 Option Award |
2007-01-23 4:59 pm |
N/A 2017-01-19 |
DOV PHARMACEUTICAL INC | DOVP | Stern Warren Charles (Sr. V.P. Drug Development) | 50,000 | $0.39 | 460,000 (Direct) |
View |
| 2006-06-28 Option Award | 2006-06-30 10:53 am | 2007-06-28 2016-06-28 |
DOV PHARMACEUTICAL INC | DOVP | Myers Scott Dunseth (Senior Vice President) | 50,000 | $2.08 | 335,000 (Direct) |
View |
| 2006-02-07 Option Award |
2006-02-09 1:52 pm |
N/A 2016-02-07 | DOV PHARMACEUTICAL INC | DOVP | Hudson Leslie (CEO and President Director) | 50,000 | $17.61 | 275,000 (Direct) | View |
|
© 2005-2008 SecForm4.Com All rights reserved. Archives: 2008 2007 2006 2005 2004 2003 Wed, 03 Dec 2008 02:27:13 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |